Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection
- 1 August 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 344 (8920) , 423-428
- https://doi.org/10.1016/s0140-6736(94)91766-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY—A CLINICOPATHOLOGIC STUDY OF 96 PATIENTSTransplantation, 1992
- Reducing the risk of infection in organ transplantationClinical Transplantation, 1991
- Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failureHepatology, 1991
- Liver, Kidney, and Thoracic Organ Transplantation Under FK 506Annals of Surgery, 1990
- Rejection in Liver TransplantationHepatology, 1989
- FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATIONThe Lancet, 1989
- Neurologic Complications of Immunosuppressive AgentsNeurologic Clinics, 1988
- Liver Allograft Rejection : An Analysis of the Use of Biopsy in Determining Outcome of RejectionThe American Journal of Surgical Pathology, 1987